Compromised anti-tumor–immune features of myeloid cell components in chronic myeloid leukemia patients

Chronic myeloid leukemia (CML) is a form of myeloproliferative neoplasm caused by the oncogenic tyrosine kinase BCR-ABL. Although tyrosine kinase inhibitors have dramatically improved the prognosis of patients with CML, several problems such as resistance and recurrence still exist. Immunological co...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Ibuki, Sasaki, Haruka, Murakami, Koichi, Nishiyama, Akira, Nakabayashi, Jun, Ichino, Motohide, Miyazaki, Takuya, Kumagai, Ken, Matsumoto, Kenji, Hagihara, Maki, Kawase, Wataru, Tachibana, Takayoshi, Tanaka, Masatsugu, Saito, Tomoyuki, Kanamori, Heiwa, Fujita, Hiroyuki, Fujisawa, Shin, Nakajima, Hideaki, Tamura, Tomohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433374/
https://www.ncbi.nlm.nih.gov/pubmed/34508131
http://dx.doi.org/10.1038/s41598-021-97371-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433374/
https://www.ncbi.nlm.nih.gov/pubmed/34508131
http://dx.doi.org/10.1038/s41598-021-97371-8

Ejemplares similares